Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2002
06/13/2002WO2002046410A2 Prostate-specific polypeptide pamp and encoding nucleic acid molecules
06/13/2002WO2002046409A2 Proteins and nucleic acids encoding same
06/13/2002WO2002046408A2 Human proteins, polynucleotides encoding them and methods of using the same
06/13/2002WO2002046407A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/13/2002WO2002046406A2 Human transporter proteins, nucleic acid molecules encoding them,and uses thereof
06/13/2002WO2002046405A1 Process for producing rfrp
06/13/2002WO2002046404A2 Schizophrenia-related voltage-gated ion channel gene and protein
06/13/2002WO2002046403A2 Regulation of human patched-like protein
06/13/2002WO2002046402A2 Regulation of human patched-like protein
06/13/2002WO2002046401A1 Use of cells derived from embryonic stem cells for increasing transplantation tolerance and for repairing damaged tissue
06/13/2002WO2002046400A2 Mutated class ii major histocompatibility proteins
06/13/2002WO2002046399A2 Mutated class i major histocompatibility proteins and complexes
06/13/2002WO2002046398A2 Nucleic acid separation using immobilized metal affinity chromatography
06/13/2002WO2002046397A1 Method for isolating and identifying effectors
06/13/2002WO2002046396A1 Method for producing a polynucleotide library
06/13/2002WO2002046393A1 Method of identifying nucleotide polymorphism
06/13/2002WO2002046391A2 Transgenic mice containing nori gene disruptions
06/13/2002WO2002046390A2 Transgenic mice containing rptpb tyrosine phosphatase gene disruptions
06/13/2002WO2002046389A2 Genes associated with allergic hypersensitivity and mast cell activation
06/13/2002WO2002046388A1 Method for expression of proteins on spore surface
06/13/2002WO2002046387A2 Plant derived hydroxy phenyl pyruvate dioxygenases (hppd) resistant against triketone herbicides and transgenic plants containing these dioxygenases
06/13/2002WO2002046386A2 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
06/13/2002WO2002046385A2 Enzymes
06/13/2002WO2002046384A2 Kinases and phosphatases sequences, and use thereof
06/13/2002WO2002046383A2 Protein modification and maintenance molecules
06/13/2002WO2002046382A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/13/2002WO2002046381A2 Method for the prevention or reduction of haze in beverages
06/13/2002WO2002046380A2 Protein kinase
06/13/2002WO2002046379A2 Glucuronyl c5-epimerase, dna encoding the same and uses thereof
06/13/2002WO2002046377A2 Abscisic acid 8'- and 7'- hydroxylase genes and related sequences from plants
06/13/2002WO2002046373A1 Method of collecting placental stem cells
06/13/2002WO2002046372A1 Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
06/13/2002WO2002046369A2 Yeast-based assays involving gpcrs
06/13/2002WO2002046367A2 Antisense modulation of cellular apoptosis susceptibility gene expression
06/13/2002WO2002046366A2 Rf2a and rf2b transcription factors
06/13/2002WO2002046364A2 Genes associated with mechanical stress, expression products therefrom, and uses thereof
06/13/2002WO2002046363A2 Improved methods for gene expression monitoring on electronic microarrays
06/13/2002WO2002046362A2 Gene associated with benign prostatic hyperplasia in humans
06/13/2002WO2002046359A2 Inducible highly productive raav packaging cell-lines
06/13/2002WO2002046238A2 Rationally designed antibodies
06/13/2002WO2002046237A2 Humanized antibodies that recognize beta amyloid peptide
06/13/2002WO2002046232A2 Multimeric single-chain antibody with multiple antigen binding
06/13/2002WO2002046230A2 G-protein coupled receptors
06/13/2002WO2002046229A2 Novel proteins and nucleic acids encoding same
06/13/2002WO2002046228A2 Receptor for b. anthracis toxin
06/13/2002WO2002046227A2 Glp-1 fusion proteins
06/13/2002WO2002046226A2 Trefoil factor 2 (tff2) peptides with moiety attached to asn15
06/13/2002WO2002046225A2 Use of sarp-1 for the treatment and/or prevention of scleroderma
06/13/2002WO2002046224A2 Compositions and methods relating to lung specific genes and proteins
06/13/2002WO2002046223A2 Compositions and methods related to the minn1 tumor suppressor gene and protein
06/13/2002WO2002046221A2 Human protein differentially expressed in alzheimer's disease's brain
06/13/2002WO2002046220A2 Sequences upstream of the carp gene, vectors containing them and uses thereof
06/13/2002WO2002046219A2 Rho-gtpase activating proteins and methods related thereto
06/13/2002WO2002046218A2 Treatment of disease by inducing cell apoptosis
06/13/2002WO2002046217A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/13/2002WO2002046216A2 Human sprouty-4 polypeptide
06/13/2002WO2002046215A2 Basb221 polypeptides and polynucleotides encoding basb221 polypeptides
06/13/2002WO2002046214A2 Immunomodulatory protein derived from the yaba monkey tumor virus
06/13/2002WO2002046212A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/13/2002WO2002046208A2 Method of producing biospecific molecules by protein trans-splicing
06/13/2002WO2002046206A1 Antisense modulation of damage-specific dna binding protein 1, p127 expression
06/13/2002WO2002045739A1 Immunomodulatory constructs and their uses
06/13/2002WO2002045737A2 Methods of treatment involving human mda-7
06/13/2002WO2002045659A2 Novel therapeutics for heart failure and aging
06/13/2002WO2002045524A2 Prolyl endoprotease from aspergillus niger
06/13/2002WO2002045523A2 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
06/13/2002WO2002045503A2 Transgenic mice containing targeted gene disruptions
06/13/2002WO2002045500A2 Transgenic mice containing ptp36 tyrosine phosphatase disruptions
06/13/2002WO2002045499A2 Transgenic mice containing deubiquitinated enzyme gene disruptions
06/13/2002WO2002045498A2 Transgenic mice containing channel protein target gene disruptions
06/13/2002WO2002045497A2 Transgenic mice containing dusp8 phosphatase gene disruptions
06/13/2002WO2002045496A2 Transenic mice containing frp-rs4 gene disruptions
06/13/2002WO2002045495A2 Transgenic mice containing targeted gene disruptions
06/13/2002WO2002045494A2 Transgenic mice containing glucagon receptor gene disruptions
06/13/2002WO2002045493A2 Transgenic mice containing phosphatase target gene disruptions
06/13/2002WO2002045492A2 Transgenic mice containing polycystin-related gene disruptions
06/13/2002WO2002045491A2 Transgenic mice containing protease target gene disruptions
06/13/2002WO2002045490A2 Method of cloning animals
06/13/2002WO2002045486A1 Method for modifying a plant phenotype
06/13/2002WO2002045485A1 Modification of sucrose synthase gene expression in plant tissue and uses therefor
06/13/2002WO2002045472A2 SEQUENCE SPECIFIC AND SEQUENCE NON-SPECIFIC METHODS AND MATERIALS FOR cDNA NORMALIZATION AND SUBTRACTION
06/13/2002WO2002028419A3 Chemokine mutants in the treatment of multiple sclerosis
06/13/2002WO2002026929A3 Kini-3 motor protein and methods for its use
06/13/2002WO2002024915A8 Dcta (c4-dicarboxylate transporter) from corynebacterium glutamicum
06/13/2002WO2002022663A3 Stress resistant retroviruses
06/13/2002WO2002022632A3 Nucleotide sequences coding for the pknd gene
06/13/2002WO2002021098A3 A method for identifying polymorphisms
06/13/2002WO2002020793A8 Chra of corynebacterium glutamicum
06/13/2002WO2002020038A3 Method for down-regulating ige
06/13/2002WO2002017948A3 Control of crop pests and animal parasites through direct neuronal uptake
06/13/2002WO2002017856A3 Compositions and methods relating to hypertension
06/13/2002WO2002012339A3 Sequences for integrin alpha-8
06/13/2002WO2002010404A3 Regulation of human masp-like serine protease
06/13/2002WO2002008418A3 Method of isolation of regulated virulence determinants from bacterial pathogens
06/13/2002WO2002008263A3 Modified virus having an altered tropism
06/13/2002WO2002007646A3 Artificial vascular grafts, and methods of producing and using same
06/13/2002WO2002006497A3 Transplastomic plants
06/13/2002WO2002006325A3 32529, a human guanine nucleotide exchange factor family member and uses thereof
06/13/2002WO2002004617A3 Novel cacao endoproteinases and their use in the production of cocoa flavour
06/13/2002WO2002004495A3 Streptococcus pyogenes antigen
1 ... 2786 2787 2788 2789 2790 2791 2792 2793 2794 2795 2796 2797 2798 2799 2800 2801 2802 2803 2804 2805 2806 ... 4023